BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34546657)

  • 1. Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan Africa.
    Eaton JW; Dwyer-Lindgren L; Gutreuter S; O'Driscoll M; Stevens O; Bajaj S; Ashton R; Hill A; Russell E; Esra R; Dolan N; Anifowoshe YO; Woodbridge M; Fellows I; Glaubius R; Haeuser E; Okonek T; Stover J; Thomas ML; Wakefield J; Wolock TM; Berry J; Sabala T; Heard N; Delgado S; Jahn A; Kalua T; Chimpandule T; Auld A; Kim E; Payne D; Johnson LF; FitzJohn RG; Wanyeki I; Mahy MI; Shiraishi RW
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25788. PubMed ID: 34546657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Indicators for Subnational Unmet Antiretroviral Therapy Need in the Health System: Updates to the Naomi Model in 2023.
    Esra R; Mmelesi M; Ketlogetswe AT; Wolock TM; Howes A; Nong T; Matlhaga MT; Ratladi S; Ramaabya D; Imai-Eaton JW
    J Acquir Immune Defic Syndr; 2024 Jan; 95(1S):e24-e33. PubMed ID: 38180736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study.
    Local Burden of Disease HIV Collaborators
    Lancet HIV; 2021 Jun; 8(6):e363-e375. PubMed ID: 34087097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Referral Systems to Integrate Health and Economic Strengthening Services for People with HIV: A Qualitative Assessment in Malawi.
    Sears C; Andersson Z; Cann M
    Glob Health Sci Pract; 2016 Dec; 4(4):610-625. PubMed ID: 28031300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the spatial relationship between primary road distance to antenatal clinics and HIV prevalence in pregnant females of Lilongwe, Malawi.
    Amuquandoh A; Escamilla V; Mofolo I; Rosenberg NE
    Int J STD AIDS; 2019 Jun; 30(7):639-646. PubMed ID: 30890119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
    Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
    BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of genital infections in medical inpatients in Blantyre, Malawi.
    Maher D; Hoffman I
    J Infect; 1995 Jul; 31(1):77-8. PubMed ID: 8522842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 10. Can routine antenatal data be used to assess HIV antiretroviral therapy coverage among pregnant women? Evaluating the validity of different data sources in the Western Cape, South Africa.
    Jacob N; Rice B; Heekes A; Johnson LF; Brinkmann S; Kufa T; Boulle A
    PLoS One; 2024; 19(4):e0291844. PubMed ID: 38635753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment coverage in a rural district in Tanzania--a modeling study using empirical data.
    Levira F; Agnarson AM; Masanja H; Zaba B; Ekström AM; Thorson A
    BMC Public Health; 2015 Feb; 15():195. PubMed ID: 25884639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
    PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 90-90-90 by 2020? Estimation and projection of the adult HIV epidemic and ART programme in Zimbabwe - 2017 to 2020.
    Bansi-Matharu L; Cambiano V; Apollo T; Yekeye R; Dirawo J; Musemburi S; Davey C; Napierala S; Fearon E; Mpofu A; Mugurungi O; Hargreaves JR; Cowan FM; Phillips AN
    J Int AIDS Soc; 2018 Nov; 21(11):e25205. PubMed ID: 30465689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels.
    Stover J; Glaubius R; Mofenson L; Dugdale CM; Davies MA; Patten G; Yiannoutsos C
    AIDS; 2019 Dec; 33 Suppl 3(Suppl 3):S227-S234. PubMed ID: 31805028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal.
    Mukandavire C; Walker J; Schwartz S; Boily MC; Danon L; Lyons C; Diouf D; Liestman B; Diouf NL; Drame F; Coly K; Muhire RSM; Thiam S; Diallo PAN; Kane CT; Ndour C; Volz E; Mishra S; Baral S; Vickerman P
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25126. PubMed ID: 30033604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnational HIV incidence trends in Malawi: large, heterogeneous declines across space.
    Wolock TM; Flaxman S; Chimpandule T; Mbiriyawanda S; Jahn A; Nyirenda R; Eaton JW
    medRxiv; 2023 Feb; ():. PubMed ID: 36778346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of active smoking among people living with HIV on antiretroviral therapy: a systematic review and meta-analysis.
    Ale BM; Amahowe F; Nganda MM; Danwang C; Wakaba NN; Almuwallad A; Ale FBG; Sanoussi A; Abdullahi SH; Bigna JJ
    Infect Dis Poverty; 2021 Feb; 10(1):12. PubMed ID: 33579391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.